Unless you were stuck under an autoclave yesterday, you've heard that another personal genomics company, Knome, announced that it was open for business.

For the bloggers' perspective, you can check out any number of sites. Bertalan Meskó jumps in with a review of Knome's website, scientific advisors, and business model -- and concludes that skepticism reigns "as Knome doesn't say a word about how they can connect the data of whole-genome sequencing to the future of my health."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.